{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2009"],"data_sharing_plan":["IPD Sharing (as of February 2022): No"],"condition":["Ovarian Cancer","Kidney Neoplasms","Gliomas","Head and Neck Cancer","Non-small Cell Lung Cancer","Colorectal Cancer","Esophageal Cancer","Pancreatic Cancer","Kidney Cancer","Breast Cancer"],"disease":["Ovarian Cancer","Kidney Neoplasms","Gliomas","Non-small Cell Lung Cancer","Colorectal Cancer","Esophageal Cancer","Head And Neck Cancer","Pancreatic Cancer","Kidney Cancer","Breast Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2077295"],"location":["United States"],"study_start_month":["7"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors","description":"The purpose of this study is to evaluate changes in tumor blood flow and disease response to the investigation agent, 177Lu-J591.","dates":{"creation":"2009-07-15"},"accession":"2077295","cross_references":{"ClinicalTrials___gov":["NCT00967577"]}}